GSK 343
-
GSK 343
structure -
-
CAS No:
1346704-33-3
-
Formula:
C31H39N7O2
-
Chemical Name:
GSK 343
-
Synonyms:
1H-Indazole-4-carboxamide,N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-;N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide;1-(1-Methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide;GSK 343
- Categories:
-
CAS No:
Description
GSK343 is a potent and selective EZH2 inhibitor with IC50 of 4 nM in a cell-free assay, showing 60 fold selectivity against EZH1, and >1000 fold selectivity against other histone methyltransferases.
GSK343 is a member of the class of indazoles that is 1-isopropyl-1H-indazole-4-carboxamide in which the nitrogen of the carboxamide group is substituted by a (6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl group and in which the indazole ring is substituted at position 6 by a 2-(4-methylpiperazin-1-yl)pyridin-4-yl group. A highly potent and selective EZH2 inhibitor (IC50 = 4 nM). It has a role as an EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor, an apoptosis inducer and an antineoplastic agent. It is a N-alkylpiperazine, a secondary carboxamide, an aminopyridine, a pyridone, a N-arylpiperazine and a member of indazoles.
Characteristics
95.4
4
white to beige to brown
1.26±0.1 g/cm3(Predicted)
797.4±60.0 °C(Predicted)
436.0±32.9 °C
1.654
DMSO: soluble15mg/mL, clear
2-8°C
Safety Information
NONH for all modes of transport
3
22
Xn
P301 + P312 + P330
H302
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 39 companies from 2 notifications to the ECHA C&L Inventory.
Computed Properties
Molecular Weight:541.7
XLogP3:4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:8
Exact Mass:541.31652351
Monoisotopic Mass:541.31652351
Topological Polar Surface Area:95.4
Heavy Atom Count:40
Complexity:986
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of GSK 343
-
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Latest News on GSK 343
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
GSK 2334470
1227911-45-6
-
GSK 690693
937174-76-0
-
Coumarin 343
55804-65-4
-
GSK 3 inhibitor XVI Formula
252917-06-9
-
BL 343 Ac Formula
102417-03-8
-
C.I. Disperse Red 343 Formula
99035-78-6
-
GSK 2830371 Structure
1404456-53-6
-
GSK 625433 Structure
885264-71-1
-
What is GSK J4 HCl
1373423-53-0
-
What is Dabrafenib
1195765-45-7